Overview

• Andalusia’s health service set a November 30 target to review pending breast screening cases, pledged checks for 2,000 affected women within two months, hired 119 extra staff to work weekends and holidays, and allocated €12 million, with oncologists’ society SAOM backing the plan.
• Clinic Barcelona is advancing the first clinical study of an antibody‑drug conjugate developed in Spain for HR+/HER2‑ metastatic breast cancer after endocrine resistance, with €150,000 in support from patients through CRIS Contra el Cáncer.
• Peru reports roughly 70% of breast cancers detected at advanced stages, with shortages of mammography equipment, specialists and innovative medicines forcing some patients to seek private radiotherapy and to pay out of pocket for newer drugs.
• October awareness drives are expanding services, with Campeche’s program adding free fairs, training and screening promotion, and Michoacán detailing fixed and mobile mammography, specialized clinics and new oncology equipment expected to boost radiotherapy capacity.
• Clinicians in Argentina stress that early detection offers very high chances of cure, and patient‑led networks such as the Enlazadas congress provide crucial information, community and psychosocial support.